What is the CVR number of EvodiaBio ApS?

EvodiaBio ApS is registered with CVR / Virk under CVR 42569283.

What is the revenue of EvodiaBio ApS?

EvodiaBio ApS reported revenue of DKK -8,4M in 2025.

EvodiaBio ApS employs 22 people as of the latest annual report.

Camilla Benedicte Kloss Fenneberg is the CEO of EvodiaBio ApS.

EvodiaBio ApS's registered address is Islevdalvej 211.

APSActive

CVR 42569283Islevdalvej 211, 2610 RødovreResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2021 · 4 years old22 employeeswww.evodiabio.com

Actively employed in the business

Name	Role	Member since
Current (1)
CB Camilla Benedicte Kloss Fenneberg Chief Executive Officer	Chief Executive Officer	2021
Former (1)
SL Simon Louis Théodore Armand Dusséaux Chief Executive Officer	Chief Executive Officer	2021 – 2021

Non-executive oversight

Name	Role	Member since
Current (5)
AF Anne Françoise Véronique Cabotin Board of Directors	Board of Directors	2022
FB Flemming Besenbacher Board of Directors	Board of Directors	2022
AH Andreas Helmut Fibig Board of Directors	Board of Directors	2022
JB Johan Bitsch Nielsen Board of Directors	Board of Directors	2024
KB Kyle Bjorn Teamey Board of Directors	Board of Directors	2025
Former (4)
LJ Lauri Johannes Reuter Board of Directors	Board of Directors	2022 – 2025
SK Sotirios Kampranis Board of Directors	Board of Directors	2021 – 2025
BV Bart Van Hooland Board of Directors	Board of Directors	2022 – 2024
VF Victor Forman Board of Directors	Board of Directors	2021 – 2022

As of last annual report

Shareholder	Type	Ownership	Votes	Since
RA Capital Planetary Health Fund, L.P.	Individual	15–19.99%	15–19.99%	2025
Danmarks Eksport- og Investeringsfond	Company	10–14.99%	10–14.99%	2025
STARFISH BIO ApS	Company	5–9.99%	5–9.99%	2025
BII Holdings A/S	Company	5–9.99%	5–9.99%	2024
Jarne Elleholm	Individual	5–9.99%	5–9.99%	2025
SDBIO ApS	Company	5–9.99%	5–9.99%	2025
NFT.VC Fund I Ky	Individual	5–9.99%	5–9.99%	2024
FormanBiotech Holding ApS	Company	5–9.99%	5–9.99%	2025
BioInnovation Institute Fonden	Company	10–14.99%	10–14.99%	2022
March EXP I HoldCo D Limited	Individual	5–9.99%	5–9.99%	2024
Busiris Vermögensverwaltung GmbH	Individual	5–9.99%	5–9.99%	2024

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.